Moderna halts development of its experimental CMV vaccine after Phase III trial fails to meet primary endpoint, leaving the field without an approved congenital CMV vaccine.
Thermo Fisher raises 2025 revenue guidance and lifts annual profit outlook after strong Q3 results.
Zebulon father confesses to killing four of his children, with a 3-year-old sibling found alive.
Moderna halts development of its experimental CMV vaccine after Phase III trial fails to meet primary endpoint, leaving the field without an approved congenital CMV vaccine.
Thermo Fisher raises 2025 revenue guidance and lifts annual profit outlook after strong Q3 results.
Zebulon father confesses to killing four of his children, with a 3-year-old sibling found alive.